Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta‐analysis
Catheterization and Cardiovascular Interventions2018Vol. 92(4), pp. 783–791
Citations Over TimeTop 10% of 2018 papers
Hitesh Raheja, Aakash Garg, Sunny Goel, Kinjal Banerjee, Gerald Hollander, Jacob Shani, Stephanie Mick, Jonathan White, Amar Krishnaswamy, Samir Kapadia
Abstract
In this small meta-analysis of DAPT versus SAPT after TAVR, DAPT did not prevent stroke, myocardial infarction or death while the risk of bleeding was higher. Results from ongoing trials are awaited to determine the best anti-thrombotic approach after TAVR.
Related Papers
- → Relative vs. absolute measures of benefit and risk: what’s the difference?(2009)68 cited
- → Evidence-based dermatology: Number needed to treat and its relation to other risk measures(2006)32 cited
- → Communicating the benefits and harms of treatments(2008)32 cited
- → Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine(2006)18 cited
- [The number needed to treat (NNT) and the number needed to harm (NNH)].(2015)